Occidental Petroleum (OXY), Exxon Mobil (XOM) and Chevron (CVX) all provide exposure to the global energy industry, but their business models are significantly different.
A simplified comparison is:
| Feature | OXY | XOM | CVX |
|---|---|---|---|
| Upstream oil & gas | Major | Major | Major |
| Refining / downstream | Limited relative exposure | Major | Major |
| Chemicals | OxyChem sold | Major | Integrated petrochemicals exposure |
| Permian | Major | Major | Major |
| Berkshire relationship | Significant | No comparable stake | No comparable stake |
| Carbon capture | 1PointFive / STRATOS | Low Carbon Solutions | Lower-carbon portfolio |
| Current major balance-sheet story | Deleveraging | Integrated scale | Hess integration |
| Commodity sensitivity | Relatively high | More integrated | More integrated |
ExxonMobil describes its three core businesses as Upstream, Product Solutions and Low Carbon Solutions. Chevron operates a large integrated upstream/downstream business and completed its acquisition of Hess in July 2025. Occidental, by contrast, sold OxyChem in January 2026 and is now more concentrated in Oil and Gas plus Midstream and Marketing.
Occidental is increasingly an upstream-centered company.
Key characteristics include:
The OxyChem sale removed one of its major non-upstream earnings streams.
ExxonMobil operates across:
Oil and gas production.
Refining, fuels, lubricants and chemicals.
Carbon capture, hydrogen and related lower-emissions technologies.
This integration can allow strength in one part of the energy value chain to partly offset weakness elsewhere.
Chevron also combines large upstream operations with downstream businesses.
Its portfolio changed materially after completing the Hess acquisition in July 2025, adding important assets including Hess's interest in Guyana.
That acquisition gives Chevron a different long-term production-growth profile from OXY.
All three respond to crude prices.
However, OXY's current business mix is relatively more upstream concentrated following OxyChem's sale.
This suggests OXY may have greater direct sensitivity to upstream commodity economics than more integrated XOM or CVX, all else equal.
That is an inference from their current business structures—not a fixed beta relationship.
All three have major Permian operations.
The Permian has become strategically important because it offers:
Occidental's Q3 2026 guidance calls for approximately 795,000–815,000 BOE/day from the Permian.
For OXY investors, Permian efficiency is one of the most important operating metrics.
Current emphasis:
debt reduction → preferred reduction → more capital flexibility.
Exxon has emphasized structural cost savings, investment growth and large shareholder distributions across an integrated portfolio. Its Q1 2026 results included $9.2 billion of shareholder distributions.
Chevron has also emphasized large shareholder returns while integrating Hess; Q1 2026 shareholder distributions were $6.0 billion.
Berkshire owns approximately 26.9% of Occidental common stock, excluding warrants.
It also holds:
Neither Exxon nor Chevron has a directly comparable Berkshire relationship.
OXY currently pays a $0.26 quarterly common dividend.
For OXY, dividend growth currently competes with debt reduction.
Exxon and Chevron's capital-return profiles are more mature, with both distributing billions of dollars through dividends and repurchases in recent quarters.
This does not automatically make one stock superior; it reflects different balance-sheet stages.
Focuses heavily on commercial Direct Air Capture and carbon removal through 1PointFive.
STRATOS targets up to 500,000 metric tons annual removal capacity when fully operational.
Operates a dedicated Low Carbon Solutions business targeting carbon capture, hydrogen and biofuels, and says it operates the largest CO₂ pipeline network in the U.S.
Chevron also invests in lower-carbon opportunities while remaining an integrated oil and gas major.
XOM and CVX have broader integrated operations.
OXY is more concentrated after selling OxyChem.
That can create:
Potentially greater upside when upstream economics are especially strong.
Less downstream/chemical diversification during an upstream downturn.
OXY's deleveraging story is more central to its current valuation thesis.
If Occidental successfully reaches:
$10 billion principal debt
and later reduces the Berkshire preferred position, equity holders could benefit from improved financial flexibility.
But the need for deleveraging also represents a current constraint.
There is no objective answer.
An investor emphasizing:
may analyze OXY more closely.
may focus on XOM.
may focus on CVX.
These are different exposures rather than interchangeable tickers.
OXYON provides tokenized economic exposure linked specifically to OXY.
It does not provide exposure to XOM or CVX.
For details, read What Is OXYON?.
Yes, but their business mixes differ significantly.
XOM and CVX have broader downstream and product operations than today's post-OxyChem Occidental.
OXY.
Occidental through 1PointFive.
No. It is linked to OXY.
This comparison is educational only. Different energy companies have different commodity, operational, balance-sheet and geographic risks. It does not identify a universally superior investment.

概要 Elon MuskのXは、CircleのUSDCなどのステーブルコインがインフルエンサーやその他のコンテンツ提供者への報酬に使用できるかどうかを検討している。 CoinDeskは8月20日、計画に詳しい人物の話として、協議が進行中であると報じた。Xは報道時点で、最終的なステーブルコイン決済商品を公に確認していなかった。 この動きは特に重要です。なぜなら、Xはクリエイターの収益化モデルも変更し

Summary Occidental Petroleum is unusual among large U.S. oil producers because it is attempting to build a commercial carbon-management business alongside conventional oil and gas. The strategy is pri

Summary A 2026 analysis of Occidental Petroleum (NYSE: OXY) should focus on six major variables: Oil prices Production Free cash flow Debt reduction Berkshire Hathaway Low Carbon Ventures The latest Q

ビットコインハードウェアウォレットメーカーのCoinkiteは、4.0.1以降のすべてのMk3ファームウェアバージョンを含むColdcardデバイスに影響を与えるシード生成の問題についてユーザーに警告しました。この警告は、セキュリティ研究者が約3,800万ドル相当の594.48 BTCの組織的な移転を調査している中で出されました。しかし、Coldcardの問題がこれらの送金を引き起こしたことを確認

Bitgetが2026年8月3日に日本居住者向けサービス終了を発表。12月31日までに未決済ポジションを決済しないと強制決済されるため、資産保有者は期限までの対応が必要です。

概要KEYTRUDAはメルク社の最も重要な医薬品フランチャイズであり、世界最大級の医薬品の一つです。メルク社の2025年Form 10-Kでは、従来型KEYTRUDAの米国における化合物特許満了時期を2028年としています。これはメルク社の投資家にとって大きな長期的な課題を生み出します:現在の四半期売上の約半分を担うフランチャイズにバイオシミラー競争が挑み始めたら、何が起こるのか?その答えにはいく

概要メルクとモデルナは、2026年8月19日に主要な第3相臨床試験のマイルストーンを発表しました。完全切除された高リスク黒色腫の患者を対象としたINTerpath-001試験では、インティスメラン・オートジーンとキイトルーダの併用療法が、主要評価項目である無再発生存期間と、主要な副次評価項目である遠隔転移なし生存期間を達成しました。両社は規制当局への申請提出について協議する予定です。これはメルクに

概要MRKONは、大手製薬会社のリスクに、トークン化された市場レイヤーを追加したものを組み合わせています。最も重要な基礎的リスクには以下が含まれます:KEYTRUDAへの依存;2028年の特許切れ;バイオシミラー競争;臨床試験の失敗;規制上の挫折;医薬品価格への圧力;パイプライン代替リスク;買収リスク;商業化ローンチの実行。さらにMRKONには以下が加わります:トラッキングリスク;流動性リスク;異